Page last updated: 2024-09-03

umifenovir and baicalin

umifenovir has been researched along with baicalin in 2 studies

Compound Research Comparison

Studies
(umifenovir)
Trials
(umifenovir)
Recent Studies (post-2010)
(umifenovir)
Studies
(baicalin)
Trials
(baicalin)
Recent Studies (post-2010) (baicalin)
234231721,43415994

Protein Interaction Comparison

ProteinTaxonomyumifenovir (IC50)baicalin (IC50)
Lysine-specific histone demethylase 1AHomo sapiens (human)3.19
Replicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus6.41
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 26.4104
Serine/threonine-protein kinase PLK1Homo sapiens (human)3.61

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Aquino, TM; Araújo-Júnior, JX; da Silva-Júnior, EF; Leoncini, GO; Rodrigues, ÉES1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1

Reviews

1 review(s) available for umifenovir and baicalin

ArticleYear
The medicinal chemistry of Chikungunya virus.
    Bioorganic & medicinal chemistry, 2017, 08-15, Volume: 25, Issue:16

    Topics: Animals; Antiviral Agents; Biological Products; Chemistry, Pharmaceutical; Chikungunya Fever; Chikungunya virus; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship

2017

Other Studies

1 other study(ies) available for umifenovir and baicalin

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023